Results 101 to 110 of about 584 (117)

CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in Mice. [PDF]

Vaccines (Basel)
Hoang-Phou S, Pal S, Slepenkin A, Abisoye-Ogunniyun A, Zhang Y, Gilmore SF, Shelby ML, Bourguet FA, Mohagheghi MV, Noy A, Rasley A, de la Maza LM, Coleman MA.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The subunit vaccine H65 + CAF01 increased the BCG- protection against Mycobacterium bovis infection in a mouse model of bovine tuberculosis

Research in Veterinary Science, 2021
Claus Aagaard, Fabiana Bigi
exaly  

Pulmonary Administration of the Liposome-Based Adjuvant CAF01: Effect of Surface Charge on Mucosal Adjuvant Function

Molecular Pharmaceutics, 2023
Peter Andersen, Aneesh Thakur, Dennis Christensen   +2 more
exaly  

Therapeutic Vaccination with Cationic Liposomes Formulated with Dioctadecyldimethylammonium and Trehalose Dibehenate (CAF01) and Peptide P10 Is Protective in Mice Infected with Paracoccidioides brasiliensis

Journal of Fungi (Basel, Switzerland), 2020
Samuel Rodrigues Dos Santos Junior, Marcelo Valdemir DE ARAUJO, Josh Nosanchuk   +2 more
exaly  

Designing CAF-adjuvanted dry powder vaccines: Spray drying preserves the adjuvant activity of CAF01

Journal of Controlled Release, 2013
Niels B Larsen, Wouter Hinrichs, Peter Andersen   +2 more
exaly  

The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge

Vaccine, 2017
Sukumar Pal, Peter Andersen
exaly  

NIR transmission spectroscopy for rapid determination of lipid and lyoprotector content in liposomal vaccine adjuvant system CAF01

European Journal of Pharmaceutics and Biopharmaceutics, 2008
Peter Andersen, Hanne Mørck Nielsen, Jukka Rantanen   +2 more
exaly  

Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder

Vaccine, 2018
Peter Andersen, Aneesh Thakur, Dennis Christensen   +2 more
exaly  

Development and Evaluation of CAF01

2017
Dennis Christensen
exaly